Literature DB >> 20528250

Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions.

Eran Ben-Arye1, Samuel Attias, Tamar Tadmor, Elad Schiff.   

Abstract

Herbal remedies are clearly a complementary and alternative modality used frequently by patients with hemato-oncological neoplasias during the course of their specific treatment. This review focuses on the potential safety and efficacy of herbs which are either used often or even on a daily basis by patients with hematological malignancies or indicated in the herbal pharmacopeias utilized by various traditional systems of medicine, in order to improve the well-being of patients with these cancers. Traditional medicine worldwide is a source for ongoing laboratory research related to the activity of herbs on cultured cell lines derived from patients with leukemia, lymphoma, and myeloma. Although the number of clinical studies in the field of hemato-oncology is limited, there appears to be potential efficacy in studies of mistletoe (Viscum album), green tea, Indian and Middle-Eastern spices, and some traditional Chinese, American, and European herbs. In addition to the potential efficacy of herbs, safety issues are also reviewed here, particularly, the documented and potential side effects, herb-drug interactions, and matters of quality control. Based on the above issues, the authors suggest enhancing doctor-patient communication regarding herbal use by adopting a patient-centered attitude based on scientific perspective.

Entities:  

Mesh:

Year:  2010        PMID: 20528250     DOI: 10.3109/10428194.2010.487622

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Integration of complementary medicine in supportive cancer care: survey of health-care providers' perspectives from 16 countries in the Middle East.

Authors:  Eran Ben-Arye; Elad Schiff; Kamer Mutafoglu; Suha Omran; Ramzi Hajjar; Haris Charalambous; Tahani Dweikat; Ibtisam Ghrayeb; Gil Bar Sela; Ibrahim Turker; Azza Hassan; Esmat Hassan; Ariela Popper-Giveon; Bashar Saad; Omar Nimri; Rejin Kebudi; Jamal Dagash; Michael Silbermann
Journal:  Support Care Cancer       Date:  2015-01-24       Impact factor: 3.603

2.  Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival.

Authors:  Li Guo; Shu-Ping Bai; Ling Zhao; Xiao-Hong Wang
Journal:  Med Oncol       Date:  2011-09-18       Impact factor: 3.064

Review 3.  Integrative oncology research in the Middle East: weaving traditional and complementary medicine in supportive care.

Authors:  Eran Ben-Arye; Mohammed Saleem Ali-Shtayeh; Mati Nejmi; Elad Schiff; Esmat Hassan; Kamer Mutafoglu; Fatma U Afifi; Rana Majed Jamous; Efraim Lev; Michael Silbermman
Journal:  Support Care Cancer       Date:  2011-03-01       Impact factor: 3.603

Review 4.  A systematic review of anticancer effects of radix astragali.

Authors:  Yeehong Jung; Uimin Jerng; Sookyung Lee
Journal:  Chin J Integr Med       Date:  2015-12-07       Impact factor: 1.978

5.  Citral induced apoptosis in MDA-MB-231 spheroid cells.

Authors:  Siyamak Ebrahimi Nigjeh; Swee Keong Yeap; Norshariza Nordin; Behnam Kamalideghan; Huynh Ky; Rozita Rosli
Journal:  BMC Complement Altern Med       Date:  2018-02-13       Impact factor: 3.659

6.  Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center.

Authors:  D M Hansra; K McIntyre; J Ramdial; S Sacks; C S Patrick; J Cutler; B McIntyre; K Feister; M Miller; A K Taylor; F Farooq; J Antunez de Mayolo; E Ahn
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-12       Impact factor: 2.629

Review 7.  Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors.

Authors:  Judith M Fouladbakhsh; Lynda Balneaves; Elizabeth Jenuwine
Journal:  J Adv Pract Oncol       Date:  2013-09

8.  Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells.

Authors:  Jie Song; Youming Chen; Donghong He; Wenhui Tan; Fang Lv; Biao Liang; Tingting Xia; Jing Li
Journal:  Cancer Manag Res       Date:  2020-04-01       Impact factor: 3.989

9.  Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation.

Authors:  Qian Huang; Jinkun Lin; Surong Huang; Jianzhen Shen
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.